Family Video Ready to 'Round It Up' for Lymphoma Again in 2014

The best fundraiser in the world of blood cancers is on again for 2014.

Beginning on March 14, Family Video, the largest privately-owned movie and game retailer in the United States, will launch its "Round It Up for Lymphoma" campaign, in which customers at the company's 750 retail locations are asked at the point of sale if they would like to round up their purchases to the nearest dollar, with the extra money going to benefit the Lymphoma Research Foundation and the University of Chicago Medicine’s lymphoma tissue bank.

'Round It Up' has been a success for three years

This extraordinarily successful fundraiser (described in more detail
HERE) is now in its third consecutive year.

The company’s first such fundraiser, in 2012, reached its goal of raising $1 million in just 17 days. Last year, it raised over $1.13 million in just 16 days.

Employee participation has played a major role in the success of the campaign, and there’s little doubt it will do so again this year.

For more information, visit the links below:

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap